01
Misconception one
"It's just anxiety — or anxiety is making it much worse."

PoTS and anxiety share many surface features — palpitations, breathlessness, chest tightness, dizziness — which makes this an understandable source of confusion. The critical difference is that PoTS symptoms are reliably and specifically postural: they occur on standing and resolve on lying down. Anxiety does not follow this pattern.

Anxiety is a frequent accompaniment to PoTS, but the evidence does not support it as a primary cause.

The symptomatic overlap between PoTS and anxiety is genuine and well recognised. Both conditions can produce palpitations, breathlessness, dizziness, and a sense of impending collapse. Where they differ is in the physiological mechanism and the postural relationship: in PoTS, a reproducible and measurable heart rate rise occurs specifically on standing, independent of psychological state. This can be demonstrated objectively with a simple active stand test.[2]

Anxiety does occur more frequently in people with PoTS than in the general population, affecting approximately 25–30% of patients. The available evidence suggests this develops in the context of living with undiagnosed or poorly managed physical symptoms, rather than preceding or driving the condition itself.[3] Treating anxiety alone, where PoTS is the underlying diagnosis, does not improve orthostatic heart rate and does not resolve symptoms.[2]

What the evidence shows
  • In a large cross-sectional survey of over 4,800 people with confirmed PoTS, 54% reported receiving an anxiety diagnosis before PoTS was identified — making it the most common preceding misdiagnosis.[1]
  • Elevated standing noradrenaline, reduced plasma volume, and evidence of small-fibre neuropathy have all been documented in PoTS — objective physiological findings that are not features of anxiety disorders.[4]
  • Anxiety symptoms in PoTS improve with effective treatment of the underlying autonomic dysfunction, consistent with anxiety being secondary to the physical condition rather than its cause.[3]
  • Cognitive behavioural therapy alone does not reduce orthostatic heart rate in PoTS, which would be expected if psychological factors were driving the cardiovascular abnormality.[2]
Clinical context

The average diagnostic delay for PoTS is 3–5 years, during which time patients often receive multiple alternative diagnoses.[1] An active stand test — lying and standing heart rate and blood pressure over 10 minutes — is a straightforward way to assess for the postural tachycardia that defines the condition, and can be performed in primary care without specialist equipment.

"I was told for three years that I needed to address my anxiety. It wasn't until I filmed my heart rate going from 68 to 124 when I stood up that anyone took me seriously."
— Composite account reflecting themes reported consistently in patient surveys
02
Misconception two
"PoTS is simply deconditioning — patients just need to exercise more."

Exercise rehabilitation is among the most effective treatments for PoTS, and deconditioning does contribute to symptoms in many patients. The evidence is clear, however, that PoTS involves measurable physiological abnormalities beyond deconditioning alone — and that the type and sequence of exercise matters considerably.

Structured exercise is effective — but the underlying physiology of PoTS is not reducible to fitness alone, and the approach to exercise requires care.

It is well established that a structured, progressive exercise programme — particularly the recumbent-based Levine protocol — produces significant improvements in plasma volume, cardiac dimensions, VO₂ max, and standing heart rate in PoTS.[5] Exercise rehabilitation is appropriately considered the most evidence-based intervention available. Understanding this, however, is different from attributing PoTS to a simple lack of fitness.

Patients with PoTS have measurable physiological abnormalities — including reduced circulating plasma volume, evidence of small-fibre autonomic neuropathy, and, in some cases, autonomic receptor autoantibodies — that exist independently of their activity level and are not fully corrected by exercise alone.[4] Additionally, the exercise programme that benefits PoTS is specific: beginning with upright high-intensity activity before postural adaptation has occurred tends to worsen symptoms and increase the likelihood that patients disengage from rehabilitation altogether.[5]

What the evidence shows
  • A structured three-month recumbent exercise programme significantly improves plasma volume, cardiac dimensions, and standing heart rate in PoTS — demonstrating that exercise works through genuine physiological mechanisms, not simply through improved general fitness.[5]
  • The programme must begin with recumbent exercise (rowing machine, swimming, recumbent cycling) before progressing to upright activity. Starting with upright high-intensity exercise consistently worsens orthostatic symptoms and is associated with high dropout rates.[5]
  • Plasma volume in PoTS is measurably lower than in healthy controls — a finding not fully explained by deconditioning, and not corrected by exercise alone without concurrent fluid and salt loading.[4]
  • Approximately 25–50% of PoTS patients have coexisting features consistent with ME/CFS, including post-exertional malaise. In this group, graded exercise is contraindicated and may worsen overall function — making careful clinical assessment essential before exercise is prescribed.[6]
Clinical context

Exercise rehabilitation in PoTS should begin with a recumbent phase, be combined with adequate fluid and salt loading, and be progressed gradually according to tolerance. For patients with coexisting ME/CFS — identifiable by the presence of post-exertional malaise — specialist input is advisable before any exercise programme is initiated.

03
Misconception three
"PoTS is rare."

PoTS is estimated to affect around 1 in 100 people — a prevalence comparable to type 1 diabetes. The impression that it is rare is understandable, since under-recognition of cases leads to under-reporting, which in turn reinforces the belief that the condition is uncommon. In reality, prevalence and recognition are two separate things.

Under-recognition of PoTS creates the impression that it is rare. The epidemiological evidence suggests otherwise.

Prevalence estimates for PoTS range from 0.2% to 1% of the general population, with the most widely cited figures clustering around 1 in 100.[7] On this basis, a typical GP with a list of 1,800 patients might expect to have 15–18 people with PoTS at any given time. Most of these individuals are likely to present with symptoms — dizziness, palpitations, fatigue, cognitive difficulty — that are among the most common reasons for consulting in primary care, but the postural nature of those symptoms may not be identified without a specific assessment.

PoTS has historically received limited coverage in undergraduate and postgraduate medical education, which means that clinicians across specialties may have had little exposure to its presentation. When a condition is not part of the diagnostic framework, its features are naturally attributed to other explanations — which is precisely what the diagnostic delay data reflects.[1]

What the evidence shows
  • Population prevalence estimates for PoTS range from 0.2% to 1%, placing it in the same category as conditions such as type 1 diabetes, epilepsy, and multiple sclerosis in terms of overall burden.[7]
  • In a survey of over 4,800 people with confirmed PoTS, the median number of healthcare professionals seen before diagnosis exceeded seven, and the average time to diagnosis was over four years — consistent with a condition whose prevalence is not matched by its diagnostic recognition.[1]
  • The COVID-19 pandemic appears to have further increased prevalence: autonomic dysfunction consistent with PoTS is estimated to affect 30–40% of people with persistent long COVID symptoms.[8]
  • A structured programme of awareness-raising among primary care teams — combined with accessible diagnostic tools such as the active stand test — has been shown to improve detection rates in pilot evaluations.[1]
Clinical context

In primary care, PoTS is worth considering when a patient presents with dizziness, palpitations, fatigue, or presyncope that is worse on standing and better on lying down — particularly in women aged 15–50, following a viral illness, or following a period of immobility. An active stand test can be performed without specialist equipment and takes around 15 minutes.

04
Misconception four
"Most people grow out of PoTS."

Spontaneous improvement does occur in a proportion of patients — particularly adolescents. This is a legitimate observation, but the evidence does not support applying it broadly across all age groups. For many adults, PoTS follows a chronic course, and outcomes are substantially better with active management than without it.

Natural history varies considerably by age and subtype. Assuming spontaneous recovery risks missing an important window for effective early intervention.

Studies of adolescent-onset PoTS do show that a meaningful proportion — roughly one-third — experience significant improvement by early adulthood, possibly related to physiological changes during growth and puberty.[9] This pattern is worth communicating to younger patients and their families. The difficulty arises when this observation is generalised to adults, where the evidence for spontaneous remission is considerably weaker.

For adults with PoTS — particularly those with an identifiable subtype (neuropathic, hyperadrenergic, or hypovolaemic) or with coexisting conditions such as hEDS or ME/CFS — full spontaneous remission is not the typical course. Long-term follow-up data indicate that most adult patients continue to experience significant symptoms without structured management, and that functional outcomes are substantially better in those who receive early, appropriate treatment.[9]

What the evidence shows
  • In adolescent-onset PoTS, around one-third of patients experience meaningful spontaneous improvement after the pubertal growth phase; the remainder continue to have symptoms into adulthood, especially where connective tissue disorders coexist.[9]
  • Long-term follow-up of adults with PoTS shows fluctuating symptoms in the majority, with full remission in a minority and significantly better functional outcomes in those receiving structured treatment compared with watchful waiting.[9]
  • Post-COVID PoTS appears to have its own natural history: two-year outcome data suggest approximately 40% achieve symptomatic remission, with outcomes strongly influenced by early exercise rehabilitation.[8]
  • Exercise rehabilitation, when initiated appropriately, produces measurable improvements in plasma volume and orthostatic tolerance that are not achieved through rest alone — supporting active rather than expectant management.[5]
Clinical context

For adolescents, it is reasonable to communicate that improvement over time is possible, while still initiating active management with fluid loading, postural advice, and appropriate exercise rehabilitation. For adults, the expectation of spontaneous recovery is less well supported by evidence, and early structured intervention — particularly exercise — is associated with better long-term outcomes.

05
Misconception five
"PoTS only affects young women."

PoTS does disproportionately affect women of reproductive age — around 80% of patients in clinical series are female, with peak incidence between 15 and 50. This pattern is real and clinically important. It becomes a problem when it operates as an exclusion criterion, leading to delayed or missed diagnosis in men, children, and older adults who present with the same underlying physiology.

The demographic pattern of PoTS is well described, but it encompasses a broader population than is sometimes appreciated.

The female predominance in PoTS is one of the most consistent findings across clinical series and population surveys, and is thought to reflect hormonal influences on blood volume regulation and autonomic function.[7] Awareness of this pattern is clinically useful — but where it becomes an obstacle to diagnosis is when the remaining 10–20% of patients, who are male, or the significant numbers of children and adolescents of both sexes, fall outside the expected profile and are therefore not assessed.

PoTS in men tends to present with similar symptoms but is more frequently associated with a hyperadrenergic phenotype, a secondary cause (such as diabetes, autonomic neuropathy, or chemotherapy), or a post-COVID onset.[7] In these cases, the orthostatic nature of the symptoms may be identified later, after other investigations have been unremarkable. New-onset PoTS presenting after age 50 warrants consideration of a secondary cause — but the diagnosis itself still applies and still benefits from the same management approach.

What the evidence shows
  • While 80–90% of classical PoTS patients in clinical series are female, the remaining 10–20% are male. Given the estimated prevalence of 1 in 100, this represents a substantial absolute number of men with undiagnosed PoTS in the UK population.[7]
  • PoTS is a recognised cause of significant morbidity in children and adolescents of both sexes, commonly presenting with school absence and functional limitation, and often attributed to other causes before the diagnosis is made.[9]
  • Post-COVID PoTS has a broader demographic profile than classical PoTS, with men and older adults represented at higher rates — reflecting the demographics of COVID-19 itself and highlighting that the typical PoTS profile cannot be assumed in this context.[8]
  • New-onset PoTS in those over 50 should prompt investigation for secondary causes including diabetic autonomic neuropathy, drug effects, and paraneoplastic autonomic dysfunction — but the diagnosis of PoTS itself remains valid and treatable.[10]
Clinical context

The demographic pattern of PoTS — predominantly affecting women aged 15–50 — is a useful prior probability when assessing new presentations, but should not function as an exclusion criterion. Any patient presenting with orthostatic symptoms (dizziness, palpitations, fatigue that is worse upright and better lying down) is a candidate for an active stand test, regardless of age or sex.

Find out more about PoTS

Whether you are exploring your own symptoms or looking for clinical guidance, these are useful next steps.